Medicaloid

GlaxoSmithKline

Novavax and Commonwealth of Australia announce agreement in principle for acquisition of Novavax COVID-19 vaccine

Medicaloid
Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the signing of a non-binding Heads of Terms...

U.K. starts building a ‘factory of the future’ to overhaul small-molecule drug production

Medicaloid
The U.K. is already working to overhaul production methods for biologic drugs, cell and gene therapies and vaccines, and, now, it’s started construction on a new innovation center...